JFS Wealth Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292 Buy
+20
New +$193 ﹤0.01% 2068
2025
Q1
Sell
-30
Closed -$495 1974
2024
Q4
$495 Sell
30
-1
-3% -$16 ﹤0.01% 1776
2024
Q3
$458 Buy
31
+1
+3% +$16 ﹤0.01% 1806
2024
Q2
$417 Hold
30
﹤0.01% 1826
2024
Q1
$472 Sell
30
-1
-3% -$15 ﹤0.01% 1793
2023
Q4
$502 Buy
31
+29
+1,450% +$475 ﹤0.01% 1804
2023
Q3
$25 Sell
2
-9
-82% -$134 ﹤0.01% 1952
2023
Q2
$177 Buy
+11
New +$181 ﹤0.01% 1892

Other funds holding NEO

JFS Wealth Advisors's NEO Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in NeoGenomics (NEO) in Q2 2026: 20 shares worth $292. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in NEO as recently as Q4 2024.

JFS Wealth Advisors first reported a position in NEO in Q2 2023 and has held it in 8 quarters since. The position peaked at $502 in Q4 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • JFS Wealth Advisors held 20 shares of NeoGenomics worth $292 as of Q2 2026.
  • NeoGenomics was a new JFS Wealth Advisors position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2068 holding.
  • JFS Wealth Advisors first reported a position in NeoGenomics in Q2 2023 and has held it in 8 quarters since.
  • JFS Wealth Advisors's NeoGenomics position peaked at $502 in Q4 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.